第七节 防控对策
早期发现病例,控制伊蚊媒介密度,做好防蚊灭蚊工作是预防控制基孔肯雅热最基本和最重要的措施。
1.控制传染源:增强基层医务人员对基孔肯雅热的认识,及时发现和报告基孔肯雅热疑似病例,对急性期的病人要求做到早诊断、早报告、早隔离、早就地治疗。隔离室应有防蚊措施,并在隔离室周围定期杀灭伊蚊成蚊和清除伊蚊孳生地。在病人较多的疫区,应就地设置临时隔离治疗点,尽量避免远距离就医,减少传播机会。
2.切断传播途径:开展爱国卫生运动,定期监测伊蚊媒介密度,通过对孳生、繁衍的蚊幼虫的户内外各种水缸、水盆、贮水池等倾倒、洗刷、换水、加盖等方式清除蚊虫孳生地,采用如敌敌畏、溴氰菊酯、马拉硫磷等灭虫剂杀灭成蚊,将蚊媒密度控制在较低水平。
3.保护易感者:目前没有针对基孔肯雅病毒的疫苗。做好个人防护,要特别注意从基孔肯雅热非流行区进入流行区人员的防护.通过喷驱蚊剂,穿长袖衣物等方法做好个人防蚊措施,使用纱门、纱窗、蚊帐等防蚊用品,避免伊蚊叮咬感染。向群众宣传关于基孔肯雅热的发生、传播、早期症状、危害及防治等基本知识,确保防蚊、灭蚊的知识和方法家喻户晓,提高群众对基孔肯雅热的自我防护意识。在流行区、流行季节尽量减少群众集会和人群流动。
(王金章)
参考文献
[1]Schwartz O,Albert ML.Biology and pathogenesis of chikungunya virus[J].Nat Rev Microbiol,2010,8(7):491-500.
[2]Couderc T,Lecuit M.Chikungunya virus pathogenesis:From bedside to bench[J].Antiviral Res,2015,121:120-131.
[3]Smith TJ,Cheng RH,Olson NH,et al.Putative receptor binding sites on alphaviruses as visualized by cryoelectron microscopy[J].Immunology,1995:10648-10652.
[4]Voss JE,Vaney MC,Duquerroy S,et al.Glycoprotein organization of Chikungunya virus particles revealed by Xray crystallography[J].Nature,2010,468:709-712.
[5]Weber C,Berberich E,von Rhein C,et al.Identification of Functional Determinants in the Chikungunya Virus E2 Protein[J].PLoS Negl Trop Dis,2017,11:e0005318.
[6]Snyder JE,Kulcsar KA,Schultz KL,et al.Functional characterization of the alphavirus TF protein[J].J Virol,2013,87:8511-8523.
[7]Weaver SC,Lecuit M.Chikungunya virus and the global spread of a mosquito-borne disease[J].N Engl J Med.2015,372(13):1231-1239.
[8]An W,Ge N,Cao Y,et al.Recent progress on chikungunya virus research[J].Virol Sin.2017,32(6):441-453.
[9]Ganesan VK,Duan B,Reid SP.Chikungunya Virus:Pathophysiology,Mechanism,and Modeling[J].Viruses.2017,9(12):368.
[10]Powers AM,Brault AC,Tesh RB,et al.Re-emergence of Chikungunya and O′nyongnyong viruses:evidence for distinct geographical lineages and distant evolutionary relationships[J].J Gen Virol.2000,81(Pt 2):471-479.
[11]Volk SM,Chen R,Tsetsarkin KA,et al.Genome-scale phylogenetic analyses of chikungunya virus reveal independent emergences of recent epidemics and various evolutionary rates[J].J Virol,2010,84:6497–6504.
[12]Leo YS,Chow AL,Tan LK,et al.Chikungunya outbreak,Singapore,2008[J].Emerg Infect Dis,2009,15:836–837.
[13]Burt FJ,Rolph MS,Rulli NE,et al.Chikungunya:a re-emerging virus[J].Lancet.2012,379(9816):662-671.
[14]卫生部办公厅.关于印发《 基孔肯雅热预防控制技术指南(2012年版)》的通知[EB/OL].( 2012-11-01)[2020-01-03].http://www.nhc.gov.cn/wjw/gfxwj/201304/0883 7445e7f54f1ca46bce6730b38582.shtml.
[15]Gérardin P,Barau G,Michault A,et al.Multidisciplinary prospective study of mother-to-child chikungunya virus infections on the island of La Réunion[J].PLoS Med,2008,5,e60.
[16]Contopoulos-Ioannidis D,Newman-Lindsay S,Chow C,et al.Mother-to-child transmission of Chikungunya virus:A systematic review and meta-analysis[J].PLoS Negl Trop Dis,2018,12(6):e0006510.
[17]Parola P,de Lamballerie X,Jourdan J,et al.Novel chikungunya virus variant in travelers returning from Indian Ocean islands[J].Emerg Infect Dis,2006,12:1493–1499.
[18]Simmons G,Brès V,Lu K,et al.High incidence of chikungunya virus and frequency of viremic blood donations during epidemic,Puerto Rico,USA,2014[J].Emerg Infect Dis,2016,22:1221–1228.
[19]Couderc T,Gangneux N,Chrétien F,et al.Chikungunya virus infection of corneal grafts[J].J Infect Dis,2012,206:851–859.
[20]Appassakij H,Silpapojakul K,Promwong C,et al.The Potential Impact of Chikungunya Virus Outbreaks on Blood Transfusion[J].Transfus Med Rev,2020,34(1):23-28.
[21]World Health Organization.Outbreak and spread of chikungunya[J].Wkly Epidemiol Rec,2007,47:409-415.
[22]World Health Organization.Chikungunya[EB/OL].( 2017-8-23 ) [2020-01-03]http://www.who.int/mediacentre/factsheets/fs327/en/.
[23]Moro ML,Gagliotti C,Silvi G,et al.Chikungunya virus in North-Eastern Italy:a seroprevalence survey[J].Am J Trop Med Hyg,2010,82(3):508-511.
[24]Grandadam M,Caro V,Plumet S,et al.Chikungunya virus,southeastern France[J].Emerg Infect Dis,2011,17(5):910-3.
[25]PAHO/ WHO.Chikungunya,PAHO/WHO data,maps and statistics[EB/OL].(2016-04-08)[2020-01-03].http:/www.paho.org/hq/index.php option=com_topics&view=rdmo re&cid=8379&Itemid=40931&lang=en.
[26]Wahid B,Ali A,Rafique S,et al.Global expansion of chikungunya virus:mapping the 64-year history[J].Int J Infect Dis,2017,58:69-76.
[27]Martí-Carvajal A,Ramon-Pardo P,Javelle E,et al.Interventions for treating patients with chikungunya virus infection-related rheumatic and musculoskeletal disorders:A systematic review[J].PLoS One,2017,12(6):e0179028.
[28]Peyrefitte CN,Rousset D,Pastorino BA,et al.Chikungunya virus,Cameroon,2006[J].Emerg Infect Dis,2007,13(5):768-771.
[29]Wangchuk S,Chinnawirotpisan P,Dorji T,et al.Chikungunya fever outbreak,Bhutan,2012[J].Emerg Infect Dis,2013,19(10):1681-1684.
[30]Souza TML,Vieira YR,Delatorre E,et al.Emergence of the East-Central-South-African genotype of Chikungunya virus in Brazil and the city of Rio de Janeiro may have occurred years before surveillance detection[J].Sci Rep,2019,9(1):2760.
[31]Fischer M,Staples JE.Arboviral Diseases Branch,National Center for Emerging and Zoonotic Infectious Diseases,CDC.Notes from the field:chikungunya virus spreads in the Americas- Caribbean and South America,2013-2014[J].MMWR Morb Mortal Wkly Rep,2014,63(22):500-501.
[32]Kariuki Njenga M,Nderitu L,Ledermann JP,et al.Tracking epidemic Chikungunya virus into the Indian Ocean from East Africa[J].J Gen Virol,2008,89(Pt 11):2754-2760.
[33]Renault P,Solet JL,Sissoko D,et al.A major epidemic of chikungunya virus infection on Reunion Island,France,2005-2006[J].Am J Trop Med Hyg,2007,77(4):727-731.(https://www.daowen.com)
[34]Yoshioka K,Nakamura J,Pérez B,et al.Effectiveness of Large-Scale Chagas Disease Vector Control Program in Nicaragua by Residual Insecticide Spraying Against Triatoma dimidiate[J].Am J Trop Med Hyg,2015,93(6):1231-1239.
[35]Tsetsarkin KA,Chen R,Yun R,et al.Multi-peaked adaptive landscape for chikungunya virus evolution predicts continued fitness optimization in Aedes albopictus mosquitoes[J].Nat Commun,2014,5:4084.
[36]Tsetsarkin KA,Weaver SC.Sequential adaptive mutations enhance efficient vector switching by Chikungunya virus and its epidemic emergence[J].PLoS Pathog,2011,7(12):e1002412.
[37]董必军,陈文州,李秀维.首次从海南岛蚊虫和蝙蝠中分离出两株基孔肯雅病毒[J].中国媒介生物学及控制杂志,1993,4:205-208。
[38]张海林,施华芳,刘丽华.从云南省蝙蝠中分离基孔肯雅病毒及血清抗体调查[J].病毒学报,1989,5:31-36.
[39]施华芳,张梅林,自登云.云南首次从患者体内分离出基孔肯雅病毒[J].中国人兽共患病杂志1990,6:2-3.
[40]郑夔,黄吉城,李华,等.全国首例输入性基孔肯雅病的实验室诊断[J].中国卫生检验杂志,2008,18(9):1806-1807.
[41]黄萌,叶雯婧,李锋平,等.福建省首例输入性基孔肯雅热病例的调查与实验室诊断(英文)[J].中国人兽共患病学报,2013,29(3):216-219.
[42]王晓光,杨瑞军,黄世腾,等.浙江省衢州市2017年输入性基孔肯雅病毒全基因组序列特征分析[J].中国媒介生物学及控制杂志,2019,30(6):621-625.
[43]何方玲,张恒娇,王娟,等.湖南省首起输入性基孔肯雅热疫情的发现与病原学诊断[J] .中华实验和临床病毒学杂志,2020,34 (02):175-179.
[44]Wu D,Wu J,Zhang QL,et al.Chikungunya outbreak in Guangdong province,China,2010[J].Emerg Infect Dis,2012,18(3):493-495.
[45]张彦,刘起勇.我国基孔肯雅热的流行状况[J].中国媒介生物学及控制杂志,2011,22(3):289-292.
[46]World Health Organization,Regional Office for South-East Asia.Guidelines for Prevention and Control of Chikungunya Fever[M].India,WHO SEARO,2009:6-7.
[47]Kam YW,Ong EK,Renia L,et al.Immuno-biology of Chikungunya and implications for disease intervention [J].Microbes Infect,2009,11(14/15):1186-1196.
[48]Labadie K,Larcher T,Joubert C,et al.Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages[J].J Clin Invest,2010,120(3):894-906.
[49]Venugopalan A,Ghorpade RP,Chopra A.Cytokines in acute chikungunya[J].PLoS One.2014,9(10):e111305.
[50]Teng TS,Foo SS,Simamarta D,et al.Viperin restricts chikungunya virus replication and pathology [J].J Clin Invest,2012,122(12):4447-4460.
[51]Schilte C,Buckwalter MR,Laird ME,et al.Cutting edge:Independent roles for IRF-3 and IRF-7 in hematopoietic and nonhematopoietic cells during host response to Chikungunya infection[J].J Immunol,2012,188:2967–2971.
[52]Fros JJ,Liu WJ,Prow NA,et al.Chikungunya virus nonstructural protein 2 inhibits type Ⅰ/Ⅱ interferon-stimulated JAK-STAT signaling [J].J Virol,2010,84(20):10877-10887.
[53]Zhang N,Zhao H,Zhang L.Fatty Acid Synthase Promotes the Palmitoylation of Chikungunya Virus nsP1[J].J Virol,2019,93(3):e01747-18.
[54]Hawman DW,Stoermer KA,Montgomery SA,et al.Chronic joint disease caused by persistent Chikungunya virus infection is controlled by the adaptive immune response [J].J Virol,2013,87(24):13878-13888.
[55]Wauquier N,Becquart P,Nkoghe D,et al.The acute phase of Chikungunya virus infection in humans is associated with strong innate immunity and T CD8 cell activation[J].J Infect Dis,2011,204,115-123.
[56]Teo TH,Lum FM,Claser C,et al.A pathogenic role for CD4+ T cells during Chikungunya virus infection in mice[J].J Immunol,2013,190(1):259-269.
[57]Poo YS,Rudd PA,Gardner J,et al.Multiple immune factors are involved in controlling acute and chronic chikungunya virus infection [J].PLoS Negl Trop Dis,2014,8(12):e3354.
[58]Taubitz W,Cramer JP,Kapaun A,et al.Chikungunya fever in travelers:clinical presentation and course[J].Clin Infect Dis,2007,45(1):e1-e4.
[59]WS/T 590-2018.基孔肯雅热诊断[S].北京:中华人民共和国国家卫生和计划生育委员会,2018:1.
[60]Kennedy AC,Fleming J,Solomon L.Chikungunya viral arthropathy:a clinical description[J].J Rheumatol,1980,7(2):231-236.
[61]Brighton SW,Simson IW.A destructive arthropathy following Chikungunya virus arthritis-a possible association[J].Clin Rheumatol,1984,3(2):253-258.
[62]Sebastian MR,Lodha R,Kabra SK.Chikungunya infection in children[J].Indian J Pediatr.2009,76(2):185-189.
[63]Simon F,Savini H,Parola P.Chikungunya:a paradigm of emergence and globalization of vector-borne diseases[J].Med Clin North Am,2008,92(6):1323-ix.
[64]Nimmannitya S,Halstead SB,Cohen SN,et al.Dengue and chikungunya virus infection in man in Thailand,1962-1964.I.Observations on hospitalized patients with hemorrhagic fever[J].Am J Trop Med Hyg,1969,18(6):954-971.
[65]Zhang X,Huang Y,Wang M,et al.Differences in genome characters and cell tropisms between two chikungunya isolates of Asian lineage and Indian Ocean lineage[J].Virol J.2018,15(1):130.
[66]Montero A.Fiebre chikungunya- Una nueva amenaza global Chikungunya fever- A new global threat[J].Med Clin (Barc),2015,145(3):118-123.
[67]Yap G,Pok KY,Lai YL,et al.Evaluation of Chikungunya Diagnostic Assays:Differences in Sensitivity of Serology Assays in Two Independent Outbreaks[J].PLoS Negl Trop Dis,2010,4(7):e753.
[68]Okabayashi T,Sasaki T,Masrinoul P,et al.Detection of chikungunya virus antigen by a novel rapid immunochromatographic test[J].J Clin Microbiol,2015,53(2):382-388.
[69]Tuekprakhon A,Puiprom O,Sasaki T,et al.Broad-spectrum monoclonal antibodies against chikungunya virus structural proteins:Promising candidates for antibody-based rapid diagnostic test development[J].PLoS One,2018,13(12):e0208851.
[70]卫生部.基孔肯雅热诊断和治疗方案[EB/OL].( 2008-06-03) .http://www.nhc.gov.cn/yzygj/s3593g/200806/7b8c803738f54072a6c5b262b164082a.shtml.
[71]Abdelnabi R,Neyts J,Delang L.Towards antivirals against chikungunya virus[J].Antiviral Res,2015,121:59-68.